PURPOSE OF REVIEW: Preventing unintentional weight and muscle loss is of crucial importance to maintain the condition and well-being of patients with cancer, improve treatment response and tolerance, and prolong survival. Anabolic resistance might explain why some cancer patients do not respond to nutritional intervention, but does recent evidence actually support this? We will discuss recent literature that casts doubt on attenuated anabolic potential in cancer. RECENT FINDINGS: Although anabolic resistance was observed in the past, more recent studies have shown that advanced cancer patients have an anabolic potential after intake of high-quality proteins. Furthermore, a consistent linear relationship is observed in cancer between (essential) amino acid availability from the diet and net protein gain. The studied cancer patients, however, were often characterized by a normal or obese body weight, following the trend in the general population, and mild systemic inflammation. Factors like recent chemotherapy, surgery, or cachexia do not seem to attenuate the anabolic potential to feeding. SUMMARY: Cancer patients have a normal anabolic potential which relates to the amount of essential amino acids in the meal. It remains to be determined if this is also the case in weak cancer patients with a short life expectancy and high systemic inflammation.
PURPOSE OF REVIEW: Preventing unintentional weight and muscle loss is of crucial importance to maintain the condition and well-being of patients with cancer, improve treatment response and tolerance, and prolong survival. Anabolic resistance might explain why some cancerpatients do not respond to nutritional intervention, but does recent evidence actually support this? We will discuss recent literature that casts doubt on attenuated anabolic potential in cancer. RECENT FINDINGS: Although anabolic resistance was observed in the past, more recent studies have shown that advanced cancerpatients have an anabolic potential after intake of high-quality proteins. Furthermore, a consistent linear relationship is observed in cancer between (essential) amino acid availability from the diet and net protein gain. The studied cancerpatients, however, were often characterized by a normal or obese body weight, following the trend in the general population, and mild systemic inflammation. Factors like recent chemotherapy, surgery, or cachexia do not seem to attenuate the anabolic potential to feeding. SUMMARY:Cancerpatients have a normal anabolic potential which relates to the amount of essential amino acids in the meal. It remains to be determined if this is also the case in weak cancerpatients with a short life expectancy and high systemic inflammation.
Authors: Thomas Schricker; Linda Wykes; Sarkis Meterissian; Roupen Hatzakorzian; Leopold Eberhart; George Carvalho; Ari Meguerditchian; Evan Nitschmann; Ralph Lattermann Journal: Ann Surg Date: 2013-01 Impact factor: 12.969
Authors: J Arends; G Bodoky; F Bozzetti; K Fearon; M Muscaritoli; G Selga; M A E van Bokhorst-de van der Schueren; M von Meyenfeldt; G Zürcher; R Fietkau; E Aulbert; B Frick; M Holm; M Kneba; H J Mestrom; A Zander Journal: Clin Nutr Date: 2006-05-12 Impact factor: 7.324
Authors: Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos Journal: J Clin Oncol Date: 2013-03-25 Impact factor: 44.544
Authors: Carla M Prado; Michael B Sawyer; Sunita Ghosh; Jessica R Lieffers; Nina Esfandiari; Sami Antoun; Vickie E Baracos Journal: Am J Clin Nutr Date: 2013-08-21 Impact factor: 7.045
Authors: Karla Sánchez-Lara; Jenny G Turcott; Eva Juárez-Hernández; Carolina Nuñez-Valencia; Geraldine Villanueva; Patricia Guevara; Martha De la Torre-Vallejo; Alejandro Mohar; Oscar Arrieta Journal: Clin Nutr Date: 2014-04-04 Impact factor: 7.324
Authors: Carla M M Prado; Yara L M Maia; Michael Ormsbee; Michael B Sawyer; Vickie E Baracos Journal: Anticancer Agents Med Chem Date: 2013-10 Impact factor: 2.505
Authors: David Pj van Dijk; Marcel Cg van de Poll; Alastair Gw Moses; Thomas Preston; Steven Wm Olde Damink; Sander S Rensen; Nicolaas Ep Deutz; Peter B Soeters; James A Ross; Kenneth Ch Fearon; Cornelis Hc Dejong Journal: J Cachexia Sarcopenia Muscle Date: 2015-04-20 Impact factor: 12.910
Authors: Frederick A Moore; Stuart M Phillips; Craig J McClain; Jayshil J Patel; Robert G Martindale Journal: Nutr Clin Pract Date: 2017-02-06 Impact factor: 3.080
Authors: Jaekwan K Park; Nicolaas E P Deutz; Clayton L Cruthirds; Sarah K Kirschner; Hangue Park; Michael L Madigan; Mariëlle P K J Engelen Journal: J Clin Med Date: 2020-02-24 Impact factor: 4.241
Authors: Emily Jeffery; Y C Gary Lee; Robert U Newton; Philippa Lyons-Wall; Joanne McVeigh; Deirdre B Fitzgerald; Leon Straker; Carolyn J Peddle-McIntyre Journal: Eur J Clin Nutr Date: 2022-01-17 Impact factor: 4.884
Authors: Laura E Ewing; Charles M Skinner; Rupak Pathak; Eric U Yee; Kim Krager; Patrick C Gurley; Stepan Melnyk; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash Journal: Int J Radiat Oncol Biol Phys Date: 2020-09-28 Impact factor: 7.038
Authors: Veridiana Mota Moreira; Claudinéia Conationi da Silva Franco; Kelly Valério Prates; Rodrigo Mello Gomes; Ana Maria Praxedes de Moraes; Tatiane Aparecida Ribeiro; Isabela Peixoto Martins; Carina Previate; Audrei Pavanello; Camila Cristina Ianoni Matiusso; Douglas Lopes Almeida; Flávio Andrade Francisco; Ananda Malta; Laize Peron Tófolo; Sandra da Silva Silveira; Lucas Paulo Jacinto Saavedra; Katia Machado; Paulo Henrique Olivieri da Silva; Gabriel S Fabrício; Kesia Palma-Rigo; Helenir Medri de Souza; Flaviane de Fátima Silva; Giuliana Regina Biazi; Taís Susane Pereira; Elaine Vieira; Rosiane Aparecida Miranda; Júlio Cezar de Oliveira; Luiz Delmar da Costa Lima; Wilson Rinaldi; Maria Ida Ravanelli; Paulo Cezar de Freitas Mathias Journal: Front Physiol Date: 2018-05-08 Impact factor: 4.566